Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Avidity Biosciences Inc RNA

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs). Its AOC platform is designed to combine the specificity of monoclonal antibodies with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. The company’s pipeline has three programs... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:RNA)

Halper Sadeh LLC Encourages TWO, RNA, CVBF, TBN Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire January 31, 2026

Halper Sadeh LLC Encourages RNA, TCBX, ATXS, FSUN Shareholders to Contact the Firm to Discuss Their Rights

PR Newswire December 1, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--TCBX, RNA, ATXS, and FSUN

PR Newswire December 1, 2025

Halper Sadeh LLC Encourages WTRG, RNA, TCBX Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire November 22, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-WTRG, RNA, FIZN, and TCBX

PR Newswire November 21, 2025

Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44

PR Newswire November 19, 2025

Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights

PR Newswire November 10, 2025

Halper Sadeh LLC Encourages WTRG, PLYM, RNA Shareholders to Contact the Firm to Discuss Their Rights

PR Newswire November 7, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Essential Utilities, Inc. (NYSE - WTRG), Cadence Bank (NYSE - CADE), Avidity Biosciences, Inc. (Nasdaq - RNA), Plymouth Industrial REIT, Inc. (NYSE - PLYM)

GlobeNewswire November 6, 2025

Opinion & Analysis (NDAQ:RNA)

No current opinion is available.

Bullboard Posts (NDAQ:RNA)

Buy buddy buy because it's taking off this morning.

Big buy out stock today at $72 per share by a good company
coolfooldumbguy - October 27, 2025

Avidity Biosciences, Inc. (NASDAQ:RNA): Pioneering the Next

http://beyondspx.com/2024/08/02/avidity-biosciences-inc-nasdaqrna-pioneering-the-next-generation-of-rna-therapeutics/
MikeTester - August 3, 2024

RNA ..... Scalped ... Yehha !

cheers 
Iseneschal - December 14, 2022

RNA ....vols are increasing

Needs to break $18 and this will be heroic !
Iseneschal - December 14, 2022

RNA .... Tick by Tick call ; )

$17.85  LoL
Iseneschal - December 14, 2022

RNA ..... Lets go !!!!

$17.70
Iseneschal - December 14, 2022

Podcasts